Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
about
A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinomaMicroarray data analysis of mouse neoplasia.DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma.Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validationHigh Expression of Retinoblastoma-Binding Protein 2 (RBP2) in Patients with Hepatocellular Carcinoma and Its Prognostic Significance.Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line in vitro and in vivo.MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells.Hepatoma with cardiac metastasis: an advanced cancer requiring advanced treatment.Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosisA novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase.XAGE-1b expression is associated with the diagnosis and early recurrence of hepatocellular carcinoma.High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets.High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.Ectokinases as novel cancer markers and drug targets in cancer therapy.The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.Reactive oxygen species alter autocrine and paracrine signaling.ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaA morpho-molecular prognostic model for hepatocellular carcinomaATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative ResectionAberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells.Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice.Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1.Ru(bpy)3(2+)/nanoporous silver-based electrochemiluminescence immunosensor for alpha fetoprotein enhanced by gold nanoparticles decorated black carbon intercalated reduced graphene oxideCannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cellsAssociation between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.New perspectives and strategy research biomarkers for hepatocellular carcinoma.Effect of thalidomide on the proliferation of hepatoma cells assessed by osteopontin levels in nude mice.Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.Is there a place for serum laminin determination in patients with liver disease and cancer?Ultrasensitive Luminescent In Vitro Detection for Tumor Markers Based on Inorganic Lanthanide Nano-Bioprobes.TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.
P2860
Q28487973-75754C58-F4F9-4437-B70E-9319AD04E257Q30986312-3D652142-5CD0-4F85-9747-0CCC162F588CQ33751222-F13F478B-4CBE-4F7F-8D29-415FB3439D84Q33751830-287F116A-01B0-4DD5-9CAE-206B0ABCE7D0Q33792639-D3FA2DB4-55CA-4F5D-95B8-460C22958F4EQ33820823-E1A492CC-9004-4338-B317-D2107EC31A36Q33843943-9EEEE4D1-C086-4E51-94C5-F3C3E5081941Q33868191-85220A13-14AA-4D71-A69D-1FDE2995AE3DQ33890280-E25E2527-CA95-47B2-AC9D-F06C2A7DDAC1Q34098691-7F1D4C00-3E15-4FDB-95EF-5C60D34F4B4DQ34141517-B1E07C40-A2DB-496A-B44C-D987BFCEBDF3Q34184578-0D7332F9-EB6B-459B-A704-E02DBEC4B9A0Q34265654-0E332804-2A09-48C8-A143-FB3735FBDA40Q34432197-E9E95DC0-ABE9-49C4-A8E1-3CB96530EEE4Q34537141-D4F7F13C-D4D4-4B43-99F6-A73E2FEDE801Q35114504-CADCA7A8-34E3-4E0C-AFB8-093DDA307531Q35197467-10AA66C9-595B-4531-86BF-D92BD279CFFFQ35236798-83FD6518-FC25-4699-B772-8C34A74A8151Q35241955-7481027B-26D8-4F39-AC51-AF055CCA9D77Q35559107-F70E4CD6-ADA3-4302-BA3A-41E397B00675Q35926503-840C0EA7-A546-4A5D-9CA2-AF927F795F4EQ35987232-470E172C-7974-435C-8285-C26F5A06CB60Q36070832-D6EC72AF-A2F3-43AA-8B5E-D680E334039AQ36089938-059CB384-0064-4602-937C-978044861E18Q36186943-0B310756-2EDB-48B3-A954-9745A0A0009EQ36224868-CADD54B8-C82E-48E7-AE36-CF2ACBF9DBD5Q36472323-D18C7FA5-46B8-4D5E-BE06-F8266726DC5EQ36523877-C29F61AE-D8C6-45E6-8890-C3028FF619C7Q36524891-9E440B62-5C12-4E58-9226-4DC2DBFCB047Q36592526-91F14347-28DB-4D3C-9EC4-F7117CD9E237Q36846587-226E3E62-F346-4FAB-B090-76FE01D7A3B9Q36883798-DDB2960A-059B-45B7-B512-2C7665EC077DQ36900631-480590FD-4A80-4284-99E9-A14AA804823DQ36904589-3BEA8241-2E8C-4E2A-A07D-614D12FC1835Q37097522-0B523F01-62BE-43E2-90FE-E5BEFA8B565DQ37205152-20B0B16C-DAAE-499A-9107-C638E739FB99Q37404644-5E94215B-0140-417B-815F-2E49F2A16118Q37584718-84CD05C6-6616-4010-B59D-95F4C5F08913Q37644875-390B86A5-8BA1-4A01-AEA3-39A18F977076Q37828640-B41E04BE-0172-442E-9ABE-AC58C4E4EDD3
P2860
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Recent progress in predictive ...... a: a review of the literature.
@ast
Recent progress in predictive ...... a: a review of the literature.
@en
type
label
Recent progress in predictive ...... a: a review of the literature.
@ast
Recent progress in predictive ...... a: a review of the literature.
@en
prefLabel
Recent progress in predictive ...... a: a review of the literature.
@ast
Recent progress in predictive ...... a: a review of the literature.
@en
P1476
Recent progress in predictive ...... a: a review of the literature.
@en
P2093
Lun-Xiu Qin
Zhao-You Tang
P2888
P304
P356
10.1007/S00432-004-0572-9
P577
2004-06-17T00:00:00Z